GlassScriptPhysician profile
Pamela Trantham
NPI 1669795399
$6,703.92
in general payments reported to CMS, 2019-2025
41 companies · $1,834 in 2025
The $1,834 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,030 · 2022: $723 · 2023: $1,287 · 2024: $1,830 · 2025: $1,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,891 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,891.11 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,134.46 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $881.67 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $713.66 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $439.01 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $431.74 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $345.84 | 2021-2025 | Xifaxan |
| Pfizer INC. | $295.49 | 2022-2025 | |
| Amgen INC. | $289.75 | 2021-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $265.13 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $223.15 | 2021-2024 | Trintellix |
| Astellas Pharma US INC | $197.63 | 2023-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $137.46 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $132.49 | 2024-2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.89 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $110.64 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Trantham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.